Annexon (ANNX) Amortizatization of Intangibles (2021 - 2026)
Annexon's (ANNX) quarterly Amortizatization of Intangibles came in at $632000.0 in Q1 2026, down 65.84% year-on-year from $1.8 million in Q1 2025, and up 49.06% quarter-over-quarter from $424000.0 in Q4 2025.
Annexon (ANNX) Amortizatization of Intangibles (2021 - 2026) Analysis & Trends
Annexon's Amortizatization of Intangibles history runs 6 years deep, the most recent figure standing at $632000.0 for Q1 2026.
- On a quarterly basis, Amortizatization of Intangibles fell 65.84% year-over-year to $632000.0 in Q1 2026; TTM through Mar 2026 was $2.8 million, a 71.47% decrease from a year earlier, with the FY2025 full-year figure at $4.0 million, down 55.77% from the prior year.
- Amortizatization of Intangibles rose to $632000.0 in Q1 2026 per ANNX's latest filing, from $424000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $3.1 million in Q3 2024 and bottomed at -$380000.0 in Q1 2022.
- The 5-year median for Amortizatization of Intangibles is $632000.0 (2026), against an average of $951058.8.
- Across the five-year window, Amortizatization of Intangibles plunged 111.11% in 2022 and soared 1062.31% in 2024, its largest moves.
- Year by year, Amortizatization of Intangibles stood at $417000.0 in 2022, then plunged by 37.65% to $260000.0 in 2023, then surged by 1062.31% to $3.0 million in 2024, then slumped by 85.97% to $424000.0 in 2025, then soared by 49.06% to $632000.0 in 2026.
- Per Business Quant, the three latest ANNX Amortizatization of Intangibles figures stand at $632000.0 (Q1 2026), $424000.0 (Q4 2025), and $475000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 3.22 Mn |
| 10 | Annexon | 1.02 Bn | 798.41 Mn | - | 632,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 632,000.00 |
| Mar 31, 2026 | 632,000.00 |
| Dec 31, 2025 | 424,000.00 |
| Dec 31, 2025 | 424,000.00 |
| Sep 30, 2025 | 475,000.00 |
| Sep 30, 2025 | 475,000.00 |
| Jun 30, 2025 | 1.26 Mn |
| Jun 30, 2025 | 1.26 Mn |
| Mar 31, 2025 | 1.85 Mn |
| Mar 31, 2025 | 1.85 Mn |
| Dec 31, 2024 | 3.02 Mn |
| Dec 31, 2024 | 3.02 Mn |
| Sep 30, 2024 | 3.10 Mn |
| Sep 30, 2024 | 3.10 Mn |
| Jun 30, 2024 | 1.80 Mn |
| Jun 30, 2024 | 1.80 Mn |
| Mar 31, 2024 | 1.14 Mn |
| Mar 31, 2024 | 1.14 Mn |
| Dec 31, 2023 | 260,000.00 |
| Dec 31, 2023 | 260,000.00 |